J9313 Medicaid Rate by State

Injection, moxetumomab pasudotox-tdfk, 0.01 mg

27 state Medicaid programs publish a fee-for-service rate for J9313 (injection, moxetumomab pasudotox-tdfk, 0.01 mg), ranging from $20.21 in Idaho to $206.25 in New Jersey.

Every state, kept current

The Rates plan

$29/mo7-day free trial

This page shows one representative rate per state for J9313. Full schedules include every locality, modifier, and age-band variant.

  • Every code on all 51 published schedules
  • Full-schedule CSV export and state network lists
  • Email alerts when a state changes its rates
Start free trial

$29/mo after the trial. Cancel anytime.

Publishing states

27

Median % of Medicare

--

Rate range

$20.21 - $206.25

J9313 rates in every publishing state

StateMedicaid rate% of MedicarePrior authVintage
Arkansas$24.11----2026
Arizona$22.22----2026
California$22.07----2026
Connecticut$23.39----2022
District of Columbia$23.39--Required2022
Iowa$22.35----2021
Idaho$20.21--Required2025
Illinois$22.76----2023
Indiana$22.20----2023
Kansas$22.07----2024
Kentucky$23.39----2026
Louisiana$22.07----2026
Michigan$23.39----2026
Mississippi$23.39----2021
Montana$23.39----2026
Nebraska$23.57----2026
New Hampshire$22.07--Not required2026
New Jersey$206.25--Not required2026
New Mexico$23.39----2025
Rhode Island$27.97----2026
South Carolina$22.29----2024
Texas$26.48*----2025
Utah$23.39*--Not required2024
Virginia$23.39----2023
Washington$22.07----2026
Wisconsin$23.39----2021
Wyoming$23.39----2022

Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.

Related drugs codes

All 198 codes from J9000 to J9601 or every drugs code by number.

Frequently asked questions

How much does Medicaid pay for J9313?

27 state Medicaid programs publish a fee-for-service rate for J9313 (injection, moxetumomab pasudotox-tdfk, 0.01 mg), ranging from $20.21 in Idaho to $206.25 in New Jersey. The full table on this page lists every publishing state's current rate.

Which state pays the most for J9313?

New Jersey publishes the highest Medicaid rate for J9313 at $206.25. Idaho publishes the lowest at $20.21.

Does J9313 require prior authorization under Medicaid?

2 of the 27 publishing states flag J9313 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".